Multiple Sclerosis Flashcards
Risk Factors for MS :
- Sex
- Age?
- Other autoimmune diagnoses such as ?
- __ hx
5.S - Excess ?
- Race such as
- Environmental such as ? (4)
- Women have a higher chance
- Ages 20-50
- Thyroid, type 1 diabetes, IBD
- Family
- Smoking
- excess body weight
- northern european
- Viral infections (MMR, EB virus)
- Geographic locations
-Sunlight exposures (Vit D deficiency)
-Changes in temp/humidity
Main sx’s of MS:
Central, Visual, Speech, throat, MSK, Sensation, bowel, urinary
See Chart!
In general, what agents would you use to treat the following :
1. ACute exacerbations
2. Relapsing MS
3. SPMS
- Define a relapse
- Steroids, “plex”
- DMT
- DMT, STeroids, others
- New neurological sx or sx’s or the worsening of an OLD sx, which lasts at least 24 hrs, and is NOT DUE to another cause such as fever, infection or heat.
DMT’s - General Considerations
1. Type of __ and __
2. __ plans
3. Vaccination status because?
4. AE risk profile
5. Patient ___
6. I
- MS , burden of disease
- pregnancy plans
- NO LIVE VACCINES ON TX
- Preferences
- Insurance
What’s PML and what’s it caused by?
What happens when you have PML?
- Progressive multifocal leukoencephalopathy
-Opportunistic CNS infection seen usually in immunocomp patients (HIV) - Caused by JC virus
- Signif neuropsych and motor dysfunction
(Visual changes, cog deficits, language probs, seizures)
Lower Effectiveness DMT’s : IFN, Plegridy, Glatiramer Acetate
- They’re all SQ except for ?
- Plegridy is?
- Which ones are self injectable IFN’s?
- Dosing varies from ?
- All are ___ that are degraded by ___
- All should be stored in ?
- Avonex (IFNBeta -1a) –> it’s IM
- SQ AND IM
- Rebif, Avonex (IFNBeta-1a)
- Betaseron and Extavia (IFNBeta-1b) - Daily to every 2 weeks
- Proteins, proteolytic enzymes
- Fridge
Lower Effectiveness DMTs: Monitoring + Counseling
- IFNS can cause new or worsening ?
- IFNS can cause ___ post injection
- Lab monitoring ?
- Glatiramer acetate can cause __ and __
- Post injection systemic reaction such as ?
-How long does it last? - Glatiramer acetate is pregnancy categ ?
- Glatiramer is dosed how often?
- Rebif (IFNB-1a) dosed?
- Avonex (IFNB-1a) dosed?
- Betaseron, extavia (IFNB-1B) dosed?
- Plegridy (IFNB-1A) dosed?
- psychiatric sx’s
- Flu like rxns
- LFTS, CBC every 6m-1 yr
- Lipoatrophy and skin necrosis
- chest tightness, flushing, SOB, anxiety, 5-15 mins and is self limited, can happen later on in therapy
- B (research in animals ok but not humans), DOC for preg
- Daily or 3x/week
- 3x/week
- 1x/week
- every other day
- every 2 weeks
Oral DMT’s : Teriflunomide (Aubagio)
–> Dose?
- BBW for ? (2)
- CI’s? (3)
- Many ___ and very long ___
- Monitoring ? (3)
- Counseling for H, H, L, J, P/C
- Take ___ or ___ food?
- Whats the accelerated elim procedure?
Dose : 7 or 14mg once daily
1. Hepatotoxicity (Careful w/concomitant use of hepatotoxic drugs)
- Fetal death and malformations (categ x) –> females of repro age MUST BE USING effetcive contraception
- Severe hepatic impairment, pregnancy, concurrent use with Leflunomide
- DDI’s, half life
- Liver panel (ALT) monthly for 6 months then periodically, CBC w/differential and BP periodically
- HA, hair thinning, liver probs, Joint pain, preg/contraception
- with or w/o
- Cholestyramine 8 grams Q8h x 11 days
- activated charcoal 50grams q12h x 11 days
ORAL DMTs : Fumarates
1. Has no __ or ___
2. Not recc in ___
3. Minimal ___
4. Whats the dosing freq? Half life?
5. Whats main lab concern?
6. F
7. ___ side effects
8. WHat needs to be monitored? (3)
- BBB , CI’s
- Pregnancy
- DDI’s
- Twice daily , very short half life
- Lymphopenia
- FLushing
- GI
- CBC w/differential , LFTS every 6-12 months, s/sx of PML
Counseling for Fumarates :
1. DMF
2. DRF
3. MMF
4. DO NOT __, __ or __ capsules
5. Most flushing and GI efffects gone in ?
6. What should be taken 30 mins before 1st dose?
7. P and C
Kim see chart for doing
- Take w or wo food; strongly recc with food, especially HIGH FAT FOOD (peanut butter)
- Take w or wo food; AVOID HIGH CALORIE >700 cals, high fat > 30g meals and avoid co admin w/alcohol
- take w or wo food
- crush, split, open
- 4 weeks to 3 months
- aspirin 81 mg
- Preg and contraception
ORAL DMT’s : S1Ps Overview
1. No ___ but many ___
2. Not recc in ___
3. Dosing freq?
4. Variable ___ but all have them . also variable__
5. Will need baseline ___
6. ___ suppressing
7. Risk of ?
8. What are CI’s? (1)
9. Warnings for?
M,S,I,P,L,P,R,A,S,T,I
- BBW, CI’s
- Pregnancy
- Once daily
- DDI’s, half life
- monitoring
- Immune
- rebound activity
- Mostly cardiac - bradycardia or anything that slows conduction
- Macular edema
* Skin malignancies
* Infections (herpes zoster)
* PML
* Liver injury
* Posterior Reversible Encephalopathy Syndrome (PRES)
* Respiratory effects
* Avoid in pregnancy
* Severe rebound after stopping
* Tumefactive MS
* Increased Blood Pressure
S1P’s : Monitoring at Baseline
1. (8) V, O, C, L, E, F, B, H
- For siponimod?
- Maintenance monitoring ? (5)
- Fingolimod First dose observation ? (3)
S1P’s : COunseling
- Food and taking the med?
- __ monitoring and expected ___
- If missed doses?
- Preg/contraception when to advice patient?
- Varicella zoster immunity, ocular coherence
tomography (OCT) for macular edema, CBC with
differential, LFTs, ECG, FEV1 if h/o COPD/asthma,
blood pressure and heart rate - CYP2C9 genotyping
- CBC with differential, LFTs every 6
months; OCT between 3-4 months then prn;
dermatologic eval prn, FEV1 prn - Baseline vitals, BP/HR every 6hrs, repeat ECG
- Take with or without food
- Lab monitoring, abnorms
- May have to repeat FDO or re-titration
- During tx and AFTER stopping
S1P’s Key Differences :
1. How does the PK vary?
2. DDI’s?
3. Dosing –> Which requires FDO? UNLESS you have ____ for the other S1P’s
4. Whats used for other S1p’s ?
- Diff absorb, distrib, metab, and elim for all
- Different DDI’s and food interactions
- Fingolimod , cardiac indications
- Dose titration
ORAL DMT’s :Cladribine (Mavenclad)
1. What are BBW’s (2) and CI’s? (5)
2. Not recc in ?
- 2 courses with 2 cycles each
- Can be ____
- When is it typically used?
- What needs to be monitored at baseline? (8)
- Maintenance?
- Incr risk of malignancy . screen prior to use
Teratogenicity : should use effective contraception during and 6 months after last tx in men AND women
CI : current malignancy
* Pregnant women and men or women not preventing a pregnancy during use or within 6 months after
* HIV infection
* Active chronic infections
* Breastfeeding on the day of treatment or 10 days after last treatment
- pregnancy
- immune suppressing
- Only after other DMT’s tried /failed
- Cancer screening, CBC with differential, HIV, Hepatitis B and C serologies, TB, varicella zoster immunity, MRI within 3 months, LFTs
- CBC w/differential 2 and 6 months after start of each course and before 2nd course
Cladribine (Mavenclad) : Counseling
1. Administer separate from ?
2. Food?
3. Careful __ with ___
4. Prophylaxis with ___ if ___
- Other oral meds by 3 hrs
- With or without
- handling, dry hands
- anti herpes medication if lymphocyte count < 200 (Acyclovir 200mg BID)